alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Here's how you know
 **Official websites use .mil** .mil
 **Secure .mil websites use HTTPS** lock () https://


Skip to main content (Press Enter).
 Toggle navigation
                
                Defense Threat Reduction Agency
                    Defense Threat Reduction Agency
            Search
                        Search Defense Threat Reduction Agency:
                            Search
                    Search Defense Threat Reduction Agency:
                        Search
    Home

    About
    
        DTRA Leadership

    DTRA History

    Mission

    Strategic Initiatives

    Foreign Malign Influence

    Agency Overview Brief (pdf)

    Agency Financial Report

    Careers & Opportunities
    
        Your Civilian Career

    Your Military Career

    Welcome Aboard

    Diversity and Inclusion

    Business
    
        DTRA Contract Award Data

    Office of Small Business

    Mentor Protege Program

    News & Media
    
        Press Center

    Contact Us

    Joint Operations Center  DTRA News
 Download
 Details
 Share
 News
 Factsheet and Link for the DOD 2023 Strategy for Countering Weapons of Mass Destruction By DTRA PA
                Defense Threat Reduction Agency
 
 SHARE
 PRINT
 Related Links 2023 Strategy for CWMD Factsheet
  2023 Strategy For CWMD
 
 ABOUT DTRA DTRA provides cross-cutting solutions to enable the Department of Defense, the United States Government, and international partners to deter strategic attack against the United States and its allies; prevent, reduce, and counter WMD and emerging threats; and prevail against WMD-armed adversaries in crisis and conflict.
 LEARN MORE News & Media»
 News Articles»
 Operating Status»
 Careers and Opportunities»
 Directions to DTRA»
 DTRA Operations Center»
 FOIA/Privacy»
 Equity, Diversity and Inclusion Office»
 Accessibility»
 IG Hotline »
 No Fear Act Data»
 Information Quality»
 CONNECT WITH US
 MORE LINKS USA.gov»
 DTRA Careers»
 Open Government»
 Plain Writing»
 DoD »
 Privacy & Security»
 508 Accessibility»
 External Link Disclaimer»
 DoD Web Policy»
  8725 John J. Kingman Rd., Fort Belvoir, Va. 22060-6221 Welcome to the Defense Threat Reduction Agency’s website. If you are looking for the official source of information about the DoD Web Policy, please visit https://dodcio.defense.gov/DoD-Web-Policy/. The Defense Threat Reduction Agency is pleased to participate in this open forum in order to increase government transparency, promote public participation, and encourage collaboration. Please note that the Defense Threat Reduction Agency does not endorse the comments or opinions provided by visitors to this site. The protection, control, and legal aspects of any information that you provided to establish your account or information that you may choose to share here is governed by the terms of service or use between you and the website. Visit the Defense Threat Reduction Agency contact page at Contact Us for information on how to send official correspondence. Site Map »
 Stay Connected
            

Hosted by Defense Media Activity - WEB.mil
#### COM. v. KENT, S.

2480 EDA 2016

Superior Court of Pennsylvania.

09/06/2017

CP-46-CR-0008036-2015 (Montgomery)

Affirmed
Exhibit 4.3


Consent of Independent Registered
Public Accounting Firm


We consent to the
reference made to our firm under the caption “Independent Registered Public Accounting Firm” in Part B of the Prospectus
and to the use of our report dated March 19, 2014, in this Registration Statement (Form S-6 No. 333-193674) of Smart Trust, Zacks
Diversified Equity & Corporate Bond Trust, Series 5.


 


/s/ Grant
Thornton LLP


Grant
Thornton LLP


Chicago, Illinois


March 19, 2014
Exhibit 32
                                                                      ----------


                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER,
                 PRESIDENT AND CHIEF FINANCIAL OFFICER (ACTING)
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      I, Douglas Mitchell, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the
Quarterly Report of Simtek Corporation on Form 10-QSB for the quarterly period
ended September 30, 2003 fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934 and that information contained
in such Form 10-QSB fairly presents in all material respects the financial
condition and results of operations of Simtek Corporation.


/s/Douglas Mitchell
---------------------------------------

Douglas Mitchell
Chief Executive Officer, President and
Chief Financial Officer (acting)
November 13, 2003
EXHIBIT 35.1 **SERVICER COMPLIANCE STATEMENT**Re:  Mercedes-Benz Financial Services USA LLC, in its capacity as Servicer (the "Servicer") under the Amended and Restated Servicing Agreement, dated as of March 1, 2009, among Daimler Trust, as Titling Trust, Daimler Title Co., as Collateral Agent, and Mercedes-Benz Financial Services USA LLC, as Lender and as Servicer (the "Servicing Agreement"), and under the 2015-A Servicing Supplement, dated as of January 1, 2015, among the same parties (the "Servicing Supplement") for the period from January 14, 2015, to December 31, 2015 (the "Reporting Period") I, Brian T. Stevens, certify that: (a) A review of the Servicer's activities during the Reporting Period and of its performance under the Servicing Agreement and the Servicing Supplement has been made under my supervision. (b) To the best of my knowledge, based on such review, the Servicer has fulfilled all of its obligations under the Servicing Agreement and the Servicing Supplement in all material respects throughout the Reporting Period. Dated:  March 22, 2016             /s/ Brian T. Stevens Name: Brian T. Stevens Title: Vice President and Controller
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 20451)    
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute on Aging Initial Review Group; Career Development for Clinicians/Health Professionals Study Section Career development for clinicians/health care professionals.                    

*Date:*                         June 6-7, 2022.                    

*Time:*                         10:00 a.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda, Gateway Building, 72001 Wisconsin Avenue, Bethesda, MD 20814 (Virtual Meeting).                    

*Contact Person:*                         Maurizio Grimaldi, Ph.D., MD, Scientific Review Officer, Scientific Review Branch, NIA (National Institute on Aging), GWY BG RM 2W200, 7201 Wisconsin Ave., Bethesda, MD 20892, 301-496-9374,                         *maurizio.grimaldi@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS)

Dated: April 1, 2022.

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-07386 Filed 4-6-22; 8:45 am]

BILLING CODE 4140-01-P
Exhibit 31.1

                                 CERTIFICATIONS

I, Harold Blomquist, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Simtek Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

     (b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

     (c) Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):

     (a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

     (b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.


Date: November 9, 2007


                                         /s/ Harold Blomquist
                                         ---------------------------------------
                                         Harold Blomquist
                                         Chief Executive Officer and President
Exhibit 10.25 Promissory Note November 7, 2013


Exhibit 10.25





		
	$9,300.00

	November 7, 2013







PROMISSORY NOTE




As hereinafter agreed Jolley Marketing Inc., jointly and severally, promises to pay to the order of McKinley Enterprise Profit Sharing Plan, Nine Thousand Three Hundred Dollars and no cents.  ($9,300.00).  It is hereby agreed that the said amount shall be payable in full twenty-four months from the date of the note.  Interest shall accrue at the rate of Eight Percent (8%) per annum will be charged on the unpaid balance until the whole amount of the principal and interest is paid.  There shall be no penalty for early payment of this note.




Should default be made in the payment of the demand note then the whole unpaid amount shall become immediately due and payable; and in the event default is made and said note is placed in the hands of an attorney for collection or suit is brought on the same, then the undersigned agrees to pay all costs and attorney’s fees that might be incurred.  If there is a lawsuit, borrower agrees upon lenders request to submit to the jurisdiction of the county of Utah County, the State of Utah.  This Note shall be governed by and construed in accordance with the laws of the State of Utah.





		
	 
	UNDERSIGNED:


	 
	Steven White


	 
	 

	 
	/s/  Steve White 


	 
	Steven White, President


	 
	Jolley Marketing, Inc.
#### J.M.M. v. W.A.G.

382 MDA 2017

Superior Court of Pennsylvania.

09/21/2017

2017-00501

(Cumberland)

Affirmed
#### Onofre CATALAN, AKA Jeff Catalan, AKA Onofre Catalan-Garcia, Petitioner, v. Jefferson B. SESSIONS III, Attorney General, Respondent.

No. 15-70857

United States Court of Appeals, Ninth Circuit.

Submitted February 13, 2018 *

Filed February 21, 2018

Rosana Cheung, Attorney, Law Office of Rosana Kit Wai Cheung, Los Angeles, CA, for Petitioner

David Nicholas Harling, Trial Attorney, U.S. Department of Justice, Office of Immigration Litigation, Washington, DC, Chief Counsel ICE, Office of the Chief Counsel, Department of Homeland Security, San Francisco, CA, for Respondent

Before: LEAVY, FERNANDEZ, and MURGUIA, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R. App. P. 34(a)(2).

MEMORANDUM **

Onofre Catalan, a native and citizen of Guatemala, petitions for review of the Board of Immigration Appeals’ (“BIA”) order denying his motion to reconsider and his fourth motion to reopen. Our jurisdiction is governed by 8 U.S.C. § 1252. We deny in part and dismiss in part the petition for review.

Catalan does not make any contentions regarding the BIA’s determination that he had not demonstrated any error of law or fact to warrant reconsideration or that his fourth motion to reopen was time- and number-barred and did not fall within any exception to those filing requirements. He thus waives any challenge to those determinations. *See Lopez-Vasquez v. Holder,*706 F.3d 1072, 1079-80 (9th Cir. 2013) (issues not specifically raised and argued in an opening brieare waived).

We lack jurisdiction to review the BIA’s decision declining to reopen Catalan’s case sua sponte based on *Morales-Garcia v. Holder,*567 F.3d 1058 (9th Cir. 2009), and Catalan’s contentions that the BIA abused its discretion in doing so do not raise a colorable legal or constitutional challenge to invoke our jurisdiction. *See Bonilla v. Lynch,*840 F.3d 575, 588 (9th Cir. 2016) (court can review BIA decisions denying sua sponte reopening only for the limited purpose of reviewing the reasoning behind the decision for legal or constitutional error).

PETITION FOR REVIEW DENIED in part; DISMISSED in part.

**

 xhiS disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3.
Exhibit 32.1

CERTIFICATION PURSUANT TO 

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, 

AS ADOPTED PURSUANT TO 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as Chief Executive Officer of DAVIDsTEA Inc. (the “Company”), does hereby certify that to my knowledge: 

 

| 8      |   |                                                                                                                                                                                                 |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | 1.     | the Company’s Form 10-K for the fiscal year ended January 28, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  |

 

 

|   |   |                                                                                                                                                                                                                     |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | 2.     | the information contained in the Company’s Form 10-K for the fiscal year ended January 28, 2017 fairly presents, in all material respects, the financial condition and results of operations of the Company. |

 

 

|            |   |                                  |
|-----------------|--------|---------------------------------------|
|            |   |                                  |
| /s/ Joel Silver |
| Name:           |   |  Joel Silver                     |
| Title:          |   | President and Chief Executive Officer |

 

Dated: April 12, 2017 

 

----
No. 11-10170.

#### In re Del Rio.

Motion of petitioner for leave to proceed *in forma pauperis*denied, and petition for writ of prohibition dismissed. See this Court’s Rule 39.8. As petitioner has repeatedly abused this Court’s process, the Clerk is directed not to accept any further petitions in noneriminal matters from petitioner unless the docketing fee required by Rule 38(a) is paid and the petition is submitted in compliance with Rule 33.1. See *Martin*v. *District of Columbia Court of Appeals,*506 U. S. 1 (1992) *(per*curiam).
I 

116TH CONGRESS 

2D SESSION H. R. 8368 

To amend title VI of the Social Security Act to permit the use of amounts 

under the Coronavirus Relief Fund for rural broadband expansion and 

improvement. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 24, 2020 

Mr. BARR introduced the following bill; which was referred to the Committee 

on Oversight and Reform 

A BILL 

To amend title VI of the Social Security Act to permit 

the use of amounts under the Coronavirus Relief Fund 

for rural broadband expansion and improvement. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Rural Broadband Ex5 pansion Act of 2020’’. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 8368 IH

1 SEC. 2. CLARIFICATION RELATING TO CORONAVIRUS RE2 LIEF FUND EXPENDITURES. 

3 (a) IN GENERAL.—Section 601 of the Social Security 

4 Act (42 U.S.C. 801) is amended by adding at the end the 

5 following: 

6 ‘‘(h) RURAL BROADBAND EXPANSION OR IMPROVE7 MENT.—For purposes of subsection (d) and notwith8 standing paragraph (3) of such subsection, necessary ex9 penditures described in such subsection shall include the 

10 expansion or improvement of infrastructure in rural areas 

11 (as defined in section 1026.35(b)(iv)(A) of title 12, Code 

12 of Federal Regulations (or any successor regulation)) for 

13 the provision of broadband internet access service (as de14 fined in section 8.1(b) of title 47, Code of Federal Regula15 tions (or any successor regulation)).’’. 

16 (b) EFFECTIVE DATE.—The amendment made by 

17 subsection (a) shall apply with respect to payments made 

18 to a State, Tribal government, or unit of local government 

19 under title VI of the Social Security Act before or after 

20 the date of enactment of this Act. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
#### COM. v. MCLAUGHLIN, C.

470 MDA 2017

Superior Court of Pennsylvania.

09/15/2017

CP-14-MD-0000278-2017 (Centre)

Affirmed
Exhibit 32.2

# CERTIFICATION PURSUANT
TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly
Report of ALARIS Medical Systems, Inc. (the Company) on Form 10-Q for the period ending
June 30, 2003, as filed with the Securities and Exchange Commission on the date hereof
(the Report), I, William C. Bopp, Sr. Vice President and Chief Financial Officer of the
Company, certify pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the
Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------

|(2) | The information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

|/s/ WILLIAM C. BOPP
William C. Bopp
Senior Vice President and Chief Financial OfficerJuly 30, 2003 |  | 
|---------------------------------------------------------------------------------------------------------------- |  |
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                         581,597
<SECURITIES>                                         0
<RECEIVABLES>                                   15,246
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,348,658
<PP&E>                                           3,715
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               1,453,481
<CURRENT-LIABILITIES>                        1,001,662
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        10,293
<OTHER-SE>                                   7,094,480
<TOTAL-LIABILITY-AND-EQUITY>                 1,453,481
<SALES>                                         16,547
<TOTAL-REVENUES>                                16,547
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               403,536
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (386,989)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (386,989)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (386,989)
<EPS-BASIC>                                     (.05)
<EPS-DILUTED>                                     (.05)


</TABLE>